Royalty deals "continue to grow, year in and year out," said Todd Davis, founding managing director of Healthcare Royalty (HC Royalty) Partners, which in October closed on Fund III, with $1.5 billion available for investing in an environment where – unlike during the correction that followed 2008 – "capital is in prolific supply."